Source: BioPortfolio

Genera Biosystems: Genera Biosystems Ltd GBI Financial and Strategic SWOT Analysis Review Report Updated 13112017 Prices from USD $300

SummaryGenera Biosystems Ltd GBL is a medical equipment company which develops and commercializes multiplexed molecular diagnostic testing products. It offers products such as RTIplex and PapType. GBL's RTIplex is a multiplexed and automated PCR based test...

Read full article »
Est. Annual Revenue
Est. Employees
CEO Avatar


Update CEO

CEO Approval Rating

- -/100